Clinical Trials Logo

Filter by:
NCT ID: NCT02536079 Recruiting - Brain Injury Clinical Trials

NeuroAiD Safe Treatment Registry

NeST
Start date: June 2014
Phase:
Study type: Observational [Patient Registry]

The NeST registry is a pro-active industry-academic collaboration to assess the use and safety of NeuroAiD in the real world setting. An online entry system was set up to allow easy data entry and retrieval of clinical information.

NCT ID: NCT02345083 Recruiting - Quality of Life Clinical Trials

Indonesia Frailty, Aging, and Longitudinal Study

INA-FRAGILE
Start date: June 2015
Phase: N/A
Study type: Observational [Patient Registry]

Frailty is a dynamic process from fit (robust) and pre-frail elderly. There is no previous study that determine the risk factors from fit to pre-frailty and pre-frailty to frailty in Indonesian elderly. This study was aimed to define the risk factors and clinical outcomes of frailty transitional status in Indonesian elderly.

NCT ID: NCT02325245 Recruiting - Pre-frail Elderly Clinical Trials

Effects of Metformin in Pre-frail Elderly

Start date: March 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the effects of metformin to prevent frailty in pre-frail non-diabetic elderly. Several outcomes measured in this study are frailty status, quality of life, handgrip strength, gait speed, and serum myostatin levels. We hypothesize that metformin for 16 weeks could prevent frailty in pre-frail elderly.

NCT ID: NCT02319473 Recruiting - Clinical trials for Acute Coronary Syndrome

Jakarta Acute Coronary Syndrome Registry

JAC Registry
Start date: January 2007
Phase: N/A
Study type: Observational

Jakarta acute coronary syndrome enrolled patients with acute coronary syndrome admitted to the emergency department of all health centers in Jakarta and the surrounding area.

NCT ID: NCT02307435 Recruiting - Non Union Fracture Clinical Trials

Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture

AMSC
Start date: August 2014
Phase: Phase 0
Study type: Interventional

Mesenchymal stem cell (MSC) is one kind of stem cell which is gained form adult tissue. Although MSC derived from autogenic bone marrow are proven to help regeneration in non union fracture and long bone defect, the aspiration process through iliac crest is invasive and painful. Therefore, alternative source of MSC which is less invasive is needed. Adipose and umbilical cord is a "waste product" that proven to contain enormous MSC. Furthermore adipose and umbilical cord as an allogenic source is more abundant in number compares to autogenic bone marrow. This enormous source need and adequate preservation technique before applied to the patient. According to that, researchers want to explore the potency of MSC from bone marrow, umbilical cord and adipose as the source of allogenic MSC and the effect of cryopreservation technique to the viability and quality of MSC. We will also compare the effectivity of MSC implantation from bone marrow, umbilical cord and adipose applied to non union fracture and long bone defect. Samples from bone marrow, umbilical cord and adipose are cultured and the viability of the cells are observed. Some of the cells are implanted directly to the patient with non union fractures and long bone defect while some are cryopreserved in liquid nitrogen -190 degree Celsius in three months. All samples are thawed and the viability of the cells are observed. Patient who are implanted by MSC allogenic will undergo clinical and radiological examination in the third, sixth and twenty second month after implantation.

NCT ID: NCT02128971 Recruiting - Anemia Clinical Trials

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Start date: April 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the gastrointestinal (GI) tolerability of 5 different iron supplements (Ferrochel®, Sumalate®,ferrous fumarate, ferrous sulfate and ferric glycinate) at the same dose (90mg) and placebo.

NCT ID: NCT02094703 Recruiting - Clinical trials for Urinary Tract Infection

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

Start date: April 2013
Phase: Phase 4
Study type: Interventional

The efficacy of Solifenacin Succinate 5 mg as adjuvant therapy and levofloxacin (500 mg) for short-term treatment to reduce symptoms in patients with symptomatic non complicated urinary tract infection in females.

NCT ID: NCT01651728 Recruiting - Clinical trials for Community-Acquired Pneumonia

Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients

Start date: July 2012
Phase: Phase 3
Study type: Interventional

The objective is to assess the effect of simvastatin on immunology, inflammatory, and coagulation responses, and mortality in elderly with pneumonia based. The primary outcome is mortality event. The hypothesis of this study is that simvastatin therapy will reduce mortality in elderly with pneumonia.

NCT ID: NCT01626625 Recruiting - Healing of Fracture Clinical Trials

Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture

Start date: April 2010
Phase: Phase 1
Study type: Interventional

The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.

NCT ID: NCT01624324 Recruiting - Ototoxicity Clinical Trials

Aminoglycoside Plasma Level Measurement in Neonates With Infection

Start date: November 2010
Phase: N/A
Study type: Observational

The aim of this study is to determine whether the plasma concentration of aminoglycoside in Indonesia neonates with infection are within safe and effective range and its association with cochlear toxicity and nephrotoxicity.